UA93361U - METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME - Google Patents
METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROMEInfo
- Publication number
- UA93361U UA93361U UAU201404777U UAU201404777U UA93361U UA 93361 U UA93361 U UA 93361U UA U201404777 U UAU201404777 U UA U201404777U UA U201404777 U UAU201404777 U UA U201404777U UA 93361 U UA93361 U UA 93361U
- Authority
- UA
- Ukraine
- Prior art keywords
- opiate
- abstrinent
- opiates
- syndrome
- treatment
- Prior art date
Links
- 229940127240 opiate Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 abstract 2
- 229960002028 atropine sulfate Drugs 0.000 abstract 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
- 206010048010 Withdrawal syndrome Diseases 0.000 abstract 1
- 238000011287 therapeutic dose Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Спосіб лікування проявів опіатного абстинентного синдрому включає використання атропіну сульфату. Атропіну сульфат використовують перорально як вегетоактивну складову частину медикаментозного комплексу. При цьому зазначений препарат застосовується із суворим дотриманням разових та добових терапевтичних доз у вигляді стандартного 0,1 % розчину препарату в кількості 1 мл на один прийом тричі на добу у вигляді крапель, які даються хворому із цукром або з водою.A method of treating manifestations of opiate withdrawal syndrome involves the use of atropine sulfate. Atropine sulfate is used orally as a vegetative component of the drug complex. In this case, the drug is applied with strict adherence to single and daily therapeutic doses in the form of a standard 0.1% solution of the drug in the amount of 1 ml once a thrice a day in the form of drops given to the patient with sugar or with water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201404777U UA93361U (en) | 2014-05-05 | 2014-05-05 | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201404777U UA93361U (en) | 2014-05-05 | 2014-05-05 | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA93361U true UA93361U (en) | 2014-09-25 |
Family
ID=56281298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201404777U UA93361U (en) | 2014-05-05 | 2014-05-05 | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA93361U (en) |
-
2014
- 2014-05-05 UA UAU201404777U patent/UA93361U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201591679A1 (en) | METHOD OF NON-TOXIC TREATMENT OF ABSTINENT, CAUSED BY MEDICINE | |
| PH12017500933A1 (en) | Sublingual administration of riluzole | |
| EA201600096A1 (en) | BENZYL-1H-PYRAZOL [3,4-B] Pyridine and their use | |
| EA201690997A1 (en) | COMPOSITION FOR APPLICATION IN THE TREATMENT OF PERSISTENT Cough | |
| PH12017500934A1 (en) | Sublingual formulation of riluzole | |
| EP4272839A3 (en) | Treatment of allergic rhinitis using a combination of mometasone and olopatadine | |
| MX2016016388A (en) | Method of treating non-small cell lung cancer and/or small cell lung cancer using thienotriazolodiazepine compounds. | |
| EP4385563A3 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
| MX2015013155A (en) | Tetrandrine family pharmaceutical formulations and method. | |
| MX2021014120A (en) | Treatment of androgen deprivation therapy associated symptoms. | |
| UA93361U (en) | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME | |
| SG10201809280PA (en) | Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders | |
| ES2446215R2 (en) | THERAPEUTIC APPLICATION OF CD44 INHIBITING AGENTS AGAINST HUMAN LYMPHOBLASTIC LEUKEMIA (ALL). | |
| UA93431U (en) | A METHOD FOR THE USE OF BELASTESIN FOR THE TREATMENT OF MANUFACTURES OF OPIATE ABSTINCENT SYNDROME | |
| UA97011U (en) | METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD | |
| RU2012115039A (en) | METHOD FOR TREATING CHRONIC ENDOMETRITIS | |
| UA107142U (en) | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTINENT SYNDROME | |
| UA111923U (en) | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME | |
| UA97663U (en) | METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS | |
| UA97449U (en) | Method for treatment of urogenital infections in patients with psoriasis arthropica | |
| UA90969U (en) | Method for treating endothelial dysfunction in patients with ischemic heart disease complicated with chronic cardiac failure at elderly age | |
| UA89203U (en) | Method for correcting vegetative dysfunction in children and adolescents with secondary cardiomyopathy | |
| UA95834U (en) | Method for treating acute ischemic stroke | |
| UA114982U (en) | METHOD OF TREATMENT OF PATIENTS WITH CHRONIC PURPLE EXTREMELY SYNUIT WITH TYPE 1 DIABETES | |
| UA107141U (en) | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTINENT SYNDROME |